Although FDA Commissioner Robert Califf has expressed support for mandatory education of opioid prescribers, an agency review of the current Risk Evaluation and Mitigation Strategy for extended-release/long-acting (ER/LA) opioids is less sanguine about such an approach.
Requiring mandatory opioid prescribing education would be a hugely challenging undertaking, affecting hundreds of thousands of prescribers and likely impacting...